Clinical Trials Directory

Trials / Conditions / Advanced Metastatic Breast Cancer

Advanced Metastatic Breast Cancer

8 registered clinical trials studyying Advanced Metastatic Breast Cancer — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the
NCT07340658
Rovi Pharmaceuticals LaboratoriesPhase 3
RecruitingAnalysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer
NCT06706557
European Institute of Oncology—
CompletedStudy for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer
NCT03096847
Novartis PharmaceuticalsPhase 3
CompletedStudy of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Bre
NCT02278120
Novartis PharmaceuticalsPhase 3
RecruitingPraegnant Breast Cancer: Early/Advanced/Metastatic
NCT02338167
University Hospital Tuebingen—
CompletedStudy of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer
NCT01958021
Novartis PharmaceuticalsPhase 3
CompletedAZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer
NCT01597388
AstraZenecaPhase 1
CompletedStudy Of Sunitinib With Capecitabine In Breast Cancer
NCT00662025
PfizerPhase 2